Bionomics Announces Positive Topline Results from the Phase 2b ...
GlobeNewswire - 28 Sep 2023ATTUNE trial met its primary endpoint showing BNC210 treatment led to a statistically significant reduction in total PTSD symptom severity at 12 weeks. ...